Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Antiretroviral restriction factors.

Hatziioannou T, Bieniasz PD.

Curr Opin Virol. 2011 Dec;1(6):526-32. doi: 10.1016/j.coviro.2011.10.007. Review.

2.

SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection.

Sze A, Olagnier D, Lin R, van Grevenynghe J, Hiscott J.

J Mol Biol. 2013 Dec 13;425(24):4981-94. doi: 10.1016/j.jmb.2013.10.022. Epub 2013 Oct 23. Review.

PMID:
24161438
3.

Antiretroviral restriction factors in mice.

Nair S, Rein A.

Virus Res. 2014 Nov 26;193:130-4. doi: 10.1016/j.virusres.2014.07.002. Epub 2014 Jul 10. Review.

4.
5.

The interface between the innate interferon response and expression of host retroviral restriction factors.

Douville RN, Hiscott J.

Cytokine. 2010 Oct-Nov;52(1-2):108-15. doi: 10.1016/j.cyto.2010.04.010. Epub 2010 Jun 2. Review.

PMID:
20627758
6.

SAMHD1 knockout mice: modeling retrovirus restriction in vivo.

Wu L.

Retrovirology. 2013 Nov 20;10:142. doi: 10.1186/1742-4690-10-142.

7.

Host restriction factors in retroviral infection: promises in virus-host interaction.

Zheng YH, Jeang KT, Tokunaga K.

Retrovirology. 2012 Dec 20;9:112. doi: 10.1186/1742-4690-9-112. Review.

8.

Endogenous retroviruses and the evolution of resistance to retroviral infection.

Best S, Le Tissier PR, Stoye JP.

Trends Microbiol. 1997 Aug;5(8):313-8. Review.

PMID:
9263409
9.

IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.

Harper MS, Barrett BS, Smith DS, Li SX, Gibbert K, Dittmer U, Hasenkrug KJ, Santiago ML.

J Immunol. 2013 Feb 15;190(4):1583-90. doi: 10.4049/jimmunol.1202920. Epub 2013 Jan 11.

10.
11.

Foamy virus infection in primates.

Murray SM, Linial ML.

J Med Primatol. 2006 Aug;35(4-5):225-35. Review.

PMID:
16872286
12.

Restriction of retroviral infection of macrophages.

Sharkey M.

Curr Top Microbiol Immunol. 2013;371:105-22. doi: 10.1007/978-3-642-37765-5_4. Review.

PMID:
23686233
13.

Innate intracellular immunity to retroviruses.

Sodroski JG.

Harvey Lect. 2004-2005;100:143-53. Review. No abstract available.

PMID:
16970178
14.

Restriction factors: a defense against retroviral infection.

Bieniasz PD.

Trends Microbiol. 2003 Jun;11(6):286-91. Review.

PMID:
12823946
15.

TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.

Imam S, Talley S, Nelson RS, Dharan A, O'Connor C, Hope TJ, Campbell EM.

J Virol. 2016 Jan 13;90(7):3400-10. doi: 10.1128/JVI.03033-15.

16.

The Evolutionary Histories of Antiretroviral Proteins SERINC3 and SERINC5 Do Not Support an Evolutionary Arms Race in Primates.

Murrell B, Vollbrecht T, Guatelli J, Wertheim JO.

J Virol. 2016 Aug 26;90(18):8085-9. doi: 10.1128/JVI.00972-16. Print 2016 Sep 15.

17.

Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody.

Nasser R, Pelegrin M, Michaud HA, Plays M, Piechaczyk M, Gros L.

J Virol. 2010 Oct;84(19):10169-81. doi: 10.1128/JVI.00568-10. Epub 2010 Jul 7.

18.

Inhibition of retroviral replication by members of the TRIM protein family.

Fletcher AJ, Towers GJ.

Curr Top Microbiol Immunol. 2013;371:29-66. doi: 10.1007/978-3-642-37765-5_2. Review.

PMID:
23686231
19.

The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3.

Kolokithas A, Rosenke K, Malik F, Hendrick D, Swanson L, Santiago ML, Portis JL, Hasenkrug KJ, Evans LH.

J Virol. 2010 Oct;84(20):10933-6. doi: 10.1128/JVI.01023-10. Epub 2010 Aug 11.

20.

Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance.

Haché G, Mansky LM, Harris RS.

AIDS Rev. 2006 Jul-Sep;8(3):148-57. Review.

PMID:
17078485

Supplemental Content

Support Center